AGENT THÉRAPEUTIQUE POUR MALADIE OSSEUSE SYSTÉMIQUE ET UTILISATION ASSOCIÉE

• 收藏
• 分享

专利权人:

NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY

发明人:

OHNO, KINJI,ISHIGURO, NAOKI,KITO, HIROSHI,MATSUSHITA, MASAKI

申请号：

EP14763917

公开号：

EP2985024A4

申请日:

2014.02.20

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The object is to provide a novel therapeutic strategy achieving high therapeutic effect on a skeletal dysplasia caused by excessive activation of FGFR3, particularly achondroplasia and hypochondroplasia. Provided is a therapeutic agent for a skeletal dysplasia, including meclizine or its pharmaceutically acceptable salt as an active ingredient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/